4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-026522
Chief Financial Officer sold 725 shares at $25.57 ($18,538)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2022-04-28 | Sale | −725 | $25.57 | $18,538 | 53,252 | D |
| Open-market sales · 725 sh · avg $25.57 · $18,538 | |||||||
Loading xslF345X03/doc4.xml…